ArticleBreast cancer research and treatment2025

Efficacy of a novel interstitial lung disease monitoring program in breast cancer patients undergoing treatment with trastuzumab-deruxtecan.

Julie Williamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.